UK markets closed

PTC Therapeutics, Inc. (PTCT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
50.75-0.65 (-1.26%)
As of 11:51AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
618,235
538,593
380,766
306,980
264,734
Cost of revenue
35,640
32,328
18,942
12,135
12,670
Gross profit
582,595
506,265
361,824
294,845
252,064
Operating expenses
Research development
578,030
540,684
477,643
257,452
171,984
Selling general and administrative
308,962
285,773
245,164
202,541
153,548
Total operating expenses
967,482
881,208
759,699
487,643
348,409
Operating income or loss
-384,887
-374,943
-397,875
-192,798
-96,345
Interest expense
89,794
86,022
56,352
-
-
Total other income/expenses net
-68,173
-57,375
51,295
-34,637
-19,211
Income before tax
-542,854
-518,340
-402,932
-239,926
-128,110
Income tax expense
12,848
5,561
35,228
11,650
-29
Income from continuing operations
-555,702
-523,901
-438,160
-251,576
-128,081
Net income
-555,702
-523,901
-438,160
-251,576
-128,081
Net income available to common shareholders
-555,702
-523,901
-438,160
-251,576
-128,081
Basic EPS
-
-7.43
-6.64
-4.27
-2.75
Diluted EPS
-
-7.43
-6.64
-4.27
-2.75
Basic average shares
-
70,466
66,028
58,863
46,576
Diluted average shares
-
70,466
66,028
58,863
46,576
EBITDA
-
-368,184
-261,708
-160,618
-70,258